{
  "id": 18988,
  "title": "GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development",
  "url": "https://urgent.news/2026/07/28/gsk-to-cut-jobs-amid-1-9bn-cost-cutting-plan-and-bid-for-faster-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-28T13:20:22.000Z",
  "source": {
    "name": "Guardian Science",
    "slug": "guardian-science",
    "url": "https://www.theguardian.com/business/2026/jul/28/gsk-cut-jobs-cost-cutting-faster-drug-development-cambridge"
  },
  "original_language": "en",
  "account": "GlaxoSmithKline (GSK) plans to reduce staff numbers as part of a £1.9 billion cost-cutting initiative to fund a £400 million investment in UK life sciences. The pharmaceuticals company aims to accelerate drug development under its new chief executive. Over 1,000 scientists will relocate to a new research and development centre in Cambridge. The company will shut its R&D facility in Stevenage, Hertfordshire, by 2029, while upgrading laboratories in Ware and relocating some employees there.",
  "summary": "Pharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site Business live – latest updates The British drugmaker GSK is to announce sweeping job cuts as part of a £1.9bn cost-cutting programme to pay for a £400m investment in UK life sciences over the next three years, including in a new research and development centre in Cambridge, as it looks…",
  "key_points": [
    "GSK plans to cut 1,000 jobs as part of £1.9bn cost-cutting plan",
    "£400m investment in UK life sciences to fund faster drug development",
    "R&D facility in Stevenage to close by 2029, labs in Ware to upgrade"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}